SB312 Alabama 2022 Session

Summary

Primary Sponsor

Arthur Orr Senator

Republican

Co-Sponsor

Jim McClendon

Session

Regular Session 2022

Title

COVID-19, occupational licensing boards prohibited to take adverse action based on physician's recommended COVID-19 treatment, health care facilities and pharmacies required to fulfill patient's COVID-19 treatment request, cause of action provided

Description

This bill would prohibit an occupational licensing board from taking adverse action against a physician who recommends a COVID-19 treatment that is not FDA-approved.

This bill would require a patient's written, informed consent to receive a physician's recommended COVID-19 treatment if the treatment is not FDA-approved.

This bill would require pharmacies to fulfill prescriptions that are not FDA-approved to treat COVID-19.

This bill would require health care facilities to provide a patient's requested off-label COVID-19 treatment.

This bill would provide a cause of action against an occupational licensing board, pharmacy, or health care facility that violates the provisions of this bill.

This bill would also provide that a health care facility, pharmacy, and licensing board that complies with this bill is immune from civil liability related to certain COVID-19 treatments.

Show more Show less

Subjects

Covid-19